IL45538A - Pharmaceutical compositons containing higher aliphatic alcohols for the treatment of secretory disorders of the prostate gland - Google Patents
Pharmaceutical compositons containing higher aliphatic alcohols for the treatment of secretory disorders of the prostate glandInfo
- Publication number
- IL45538A IL45538A IL45538A IL4553874A IL45538A IL 45538 A IL45538 A IL 45538A IL 45538 A IL45538 A IL 45538A IL 4553874 A IL4553874 A IL 4553874A IL 45538 A IL45538 A IL 45538A
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- aliphatic alcohols
- prostate gland
- higher aliphatic
- containing higher
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
- C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4056873A GB1459233A (en) | 1973-08-29 | 1973-08-29 | Medicament containing a higher alkanol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL45538A0 IL45538A0 (en) | 1974-11-29 |
| IL45538A true IL45538A (en) | 1978-06-15 |
Family
ID=10415549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL45538A IL45538A (en) | 1973-08-29 | 1974-08-26 | Pharmaceutical compositons containing higher aliphatic alcohols for the treatment of secretory disorders of the prostate gland |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4186211A (fr) |
| JP (1) | JPS5076220A (fr) |
| AR (1) | AR205721A1 (fr) |
| BE (1) | BE819296A (fr) |
| CA (1) | CA1036940A (fr) |
| CH (1) | CH593218A5 (fr) |
| DE (1) | DE2440436C3 (fr) |
| DK (1) | DK456674A (fr) |
| ES (1) | ES429585A1 (fr) |
| FI (1) | FI251974A (fr) |
| FR (1) | FR2242080B1 (fr) |
| GB (1) | GB1459233A (fr) |
| IE (1) | IE39671B1 (fr) |
| IL (1) | IL45538A (fr) |
| NL (1) | NL7411312A (fr) |
| NO (1) | NO743077L (fr) |
| SE (1) | SE7410889L (fr) |
| ZA (1) | ZA745513B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209533A (en) | 1979-01-25 | 1980-06-24 | University Of Pittsburgh | Antibacterial agent and method |
| US4340628A (en) | 1979-01-25 | 1982-07-20 | Gilbertson John R | Antibacterial agent and method |
| US4372978A (en) | 1979-11-26 | 1983-02-08 | University Of Pittsburgh | Antibacterial agent and method |
| DE3348493C2 (de) * | 1982-05-28 | 1998-09-17 | Eisai Co Ltd | Verwendung von Docosanol zur Behandlung und Prophylaxe von durch Immunmangelerscheinungen verursachten Infektionskrankheiten |
| FR2532845B1 (fr) * | 1982-05-28 | 1988-01-15 | Eisai Co Ltd | Composition pharmaceutique comprenant a titre de principe actif le docosanol |
| DE3318989C2 (de) * | 1982-05-28 | 1996-11-21 | Eisai Co Ltd | ß,gamma-Dihydropolyprenylalkoholderivate und diese enthaltende Arzneimittel und deren Verwendung |
| IT1213176B (it) * | 1984-06-11 | 1989-12-14 | Milano A | Composizioni e composti per il trattamento dell'adenoma prostatico. |
| US5071879A (en) * | 1989-04-28 | 1991-12-10 | Lidak Pharmaceuticals | Systemic antiviral treatment |
| US5070107A (en) * | 1989-04-28 | 1991-12-03 | Lidak Pharmaceuticals | Systemic antiviral treatment |
| US5166219A (en) * | 1989-11-02 | 1992-11-24 | Lidak Pharmaceuticals | Systemic anti-inflammatory treatment |
| WO1995016434A1 (fr) * | 1993-12-13 | 1995-06-22 | Lidak Pharmaceuticals | Formulations d'alcool c20 a c28 a base d'ester de sucrose |
| US5952392A (en) * | 1996-09-17 | 1999-09-14 | Avanir Pharmaceuticals | Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition |
| US6440980B1 (en) | 1996-09-17 | 2002-08-27 | Avanir Pharmaceuticals | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| US5948822A (en) | 1996-12-17 | 1999-09-07 | Lidak Pharmaceuticals | Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols |
| PT102410A (pt) * | 2000-02-03 | 2001-08-30 | Qualitas Lab | Extraccao da fraccao ceroide do residuo resinoso de fabricacao de aglomerado negro de cortica com fluido supercritico |
| EA200400535A1 (ru) * | 2001-10-16 | 2005-06-30 | Аванир Фармасютикалз | ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ |
| US7214394B2 (en) * | 2002-05-31 | 2007-05-08 | Archer-Daniels-Midland Company | Policosanol compositions, extraction from novel sources, and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3031376A (en) * | 1956-10-11 | 1962-04-24 | Levin | Compositions comprising octacosanol, triacontanol, tetracosanol, or hexacosanol, andmethods employing same |
| US3226295A (en) * | 1960-02-08 | 1965-12-28 | Carlos C Goetz | Method of making cetyl alcohol emulsions |
| US3646215A (en) * | 1969-11-26 | 1972-02-29 | Commodity Improvements Inc | Heptadecanol for medical purposes |
| US3929869A (en) * | 1972-06-29 | 1975-12-30 | Labaz | Pentanol derivatives |
-
1973
- 1973-08-29 GB GB4056873A patent/GB1459233A/en not_active Expired
-
1974
- 1974-01-01 AR AR255339A patent/AR205721A1/es active
- 1974-08-20 FR FR7428617A patent/FR2242080B1/fr not_active Expired
- 1974-08-22 IE IE1744/74A patent/IE39671B1/xx unknown
- 1974-08-23 DE DE2440436A patent/DE2440436C3/de not_active Expired
- 1974-08-26 NL NL7411312A patent/NL7411312A/xx not_active Application Discontinuation
- 1974-08-26 CH CH1158774A patent/CH593218A5/xx not_active IP Right Cessation
- 1974-08-26 IL IL45538A patent/IL45538A/xx unknown
- 1974-08-27 ES ES429585A patent/ES429585A1/es not_active Expired
- 1974-08-27 CA CA207,936A patent/CA1036940A/fr not_active Expired
- 1974-08-28 SE SE7410889A patent/SE7410889L/xx unknown
- 1974-08-28 DK DK456674A patent/DK456674A/da not_active Application Discontinuation
- 1974-08-28 FI FI2519/74A patent/FI251974A/fi unknown
- 1974-08-28 BE BE147990A patent/BE819296A/fr not_active IP Right Cessation
- 1974-08-28 NO NO743077A patent/NO743077L/no unknown
- 1974-08-28 ZA ZA00745513A patent/ZA745513B/xx unknown
- 1974-08-29 JP JP49098448A patent/JPS5076220A/ja active Pending
- 1974-08-30 US US05/502,036 patent/US4186211A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU7277374A (en) | 1976-03-04 |
| ES429585A1 (es) | 1976-09-16 |
| JPS5076220A (fr) | 1975-06-21 |
| US4186211A (en) | 1980-01-29 |
| FI251974A (fr) | 1975-03-01 |
| IE39671L (en) | 1975-02-28 |
| DE2440436A1 (de) | 1975-03-06 |
| FR2242080B1 (fr) | 1978-07-21 |
| BE819296A (fr) | 1974-12-16 |
| IE39671B1 (en) | 1978-12-06 |
| GB1459233A (en) | 1976-12-22 |
| AR205721A1 (es) | 1976-05-31 |
| ZA745513B (en) | 1975-08-27 |
| CA1036940A (fr) | 1978-08-22 |
| IL45538A0 (en) | 1974-11-29 |
| NL7411312A (nl) | 1975-03-04 |
| DK456674A (fr) | 1975-04-28 |
| DE2440436B2 (de) | 1981-02-26 |
| NO743077L (fr) | 1975-03-24 |
| DE2440436C3 (de) | 1982-03-18 |
| SE7410889L (fr) | 1975-03-03 |
| FR2242080A1 (fr) | 1975-03-28 |
| CH593218A5 (fr) | 1977-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL45538A (en) | Pharmaceutical compositons containing higher aliphatic alcohols for the treatment of secretory disorders of the prostate gland | |
| IT1024418B (it) | Procedimento ed impianto per il trattamento di melasse | |
| IT1004938B (it) | Impianto per il trattamento di rifiuti | |
| ZA725521B (en) | Agent for the regulation of plant growth | |
| ZA723325B (en) | Agent for the regulation of plant growth | |
| ZA744441B (en) | Device for the administration of powders | |
| CA1024749A (fr) | Traitement du combustible nucleaire irradie | |
| IL43455A0 (en) | Methods of disinfection | |
| ZA742728B (en) | Pharmaceutical composition for the treatment of coronaric ailments | |
| IL45647A0 (en) | Process for the manufacture of cyclopropanecarbonitrile | |
| ZA743159B (en) | Compounds for the treatment of calcific tumors | |
| ZA715095B (en) | Process for the preparation of percarboxylic acid | |
| IT1022978B (it) | Impianto per il trattamento di animali | |
| IL44875A0 (en) | Process for the 11a-dehalogenation of 11a-halotetracycline | |
| ZA718389B (en) | Process for the production of new herbicidal active substances | |
| PH12696A (en) | Esters of 4-hydroxy-2-9-dioxatricyclo-(3,1,o3,7)decanes | |
| ZA75607B (en) | Pharmaceutical composition for the treatment of cancer | |
| CA647652A (en) | Process for the preparation of stabilized linear polyureas | |
| ZA706255B (en) | Formulation for the treatment of psoriasis | |
| CA952537A (en) | Process for the preparation of polyether thioethers | |
| CA978857A (en) | Formulation for the treatment of psoriasis | |
| IT954572B (it) | Sistema per il controllo dell avan zamento della tavola di rettifica trici elettrolitiche | |
| ZA738739B (en) | New system for the manufacture of furniture | |
| CA841574A (en) | Process for the purification of biologically active preparations | |
| AU7330874A (en) | Treatment of asthma |